Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 94

    1.

    Chronic on acute renal failure: long-term implications of severe acute kidney injury.

    Waikar SS, Winkelmayer WC.

    JAMA. 2009 Sep 16;302(11):1227-9. No abstract available. PMID: 19755705 [PubMed - indexed for MEDLINE]Related articles

    2.

    Evolving statistical methods to facilitate evaluation of the causal association between erythropoiesis-stimulating agent dose and mortality in nonexperimental research: strengths and limitations.

    Bradbury BD, Brookhart MA, Winkelmayer WC, Critchlow CW, Kilpatrick RD, Joffe MM, Feldman HI, Acquavella JF, Wang O, Rothman KJ.

    Am J Kidney Dis. 2009 Sep;54(3):554-60. Epub 2009 Jul 9. Review.PMID: 19592144 [PubMed - indexed for MEDLINE]Related articles

    3.

    Greater Epoetin alfa (EPO) doses and short-term mortality risk among hemodialysis patients with hemoglobin levels less than 11 g/dL.

    Bradbury BD, Do TP, Winkelmayer WC, Critchlow CW, Brookhart MA.

    Pharmacoepidemiol Drug Saf. 2009 Oct;18(10):932-40.PMID: 19572312 [PubMed - in process]Related articles

    4.

    Lessons from geographic variations in predialysis nephrology care.

    Winkelmayer WC.

    J Am Soc Nephrol. 2009 May;20(5):930-2. Epub 2009 Apr 23. No abstract available. PMID: 19389840 [PubMed - indexed for MEDLINE]Related articles

    5.

    Altitude and all-cause mortality in incident dialysis patients.

    Winkelmayer WC, Liu J, Brookhart MA.

    JAMA. 2009 Feb 4;301(5):508-12.PMID: 19190315 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Comparison of cardiovascular outcomes in elderly patients with diabetes who initiated rosiglitazone vs pioglitazone therapy.

    Winkelmayer WC, Setoguchi S, Levin R, Solomon DH.

    Arch Intern Med. 2008 Nov 24;168(21):2368-75.PMID: 19029503 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Nonselective and cyclooxygenase-2-selective NSAIDs and acute kidney injury.

    Winkelmayer WC, Waikar SS, Mogun H, Solomon DH.

    Am J Med. 2008 Dec;121(12):1092-8.PMID: 19028206 [PubMed - indexed for MEDLINE]Related articles

    8.

    Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients.

    Choudhry NK, Setoguchi S, Levin R, Winkelmayer WC, Shrank WH.

    Pharmacoepidemiol Drug Saf. 2008 Dec;17(12):1189-96.PMID: 18956426 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Associations of kidney function with cardiovascular medication use after myocardial infarction.

    Winkelmayer WC, Levin R, Setoguchi S.

    Clin J Am Soc Nephrol. 2008 Sep;3(5):1415-22. Epub 2008 Jul 9.PMID: 18614775 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Gender differences in the management and prognosis of myocardial infarction among patients > or = 65 years of age.

    Setoguchi S, Solomon DH, Levin R, Winkelmayer WC.

    Am J Cardiol. 2008 Jun 1;101(11):1531-6. Epub 2008 Mar 26.PMID: 18489928 [PubMed - indexed for MEDLINE]Related articles

    11.

    Educational level as a determinant of access to and outcomes after kidney transplantation in the United States.

    Schaeffner ES, Mehta J, Winkelmayer WC.

    Am J Kidney Dis. 2008 May;51(5):811-8. Epub 2008 Apr 3.PMID: 18436092 [PubMed - indexed for MEDLINE]Related articles

    12.

    The effect of altitude on dosing and response to erythropoietin in ESRD.

    Brookhart MA, Schneeweiss S, Avorn J, Bradbury BD, Rothman KJ, Fischer M, Mehta J, Winkelmayer WC.

    J Am Soc Nephrol. 2008 Jul;19(7):1389-95. Epub 2008 Apr 2.PMID: 18385423 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis.

    Setoguchi S, Glynn RJ, Avorn J, Mittleman MA, Levin R, Winkelmayer WC.

    J Am Coll Cardiol. 2008 Apr 1;51(13):1247-54.PMID: 18371553 [PubMed - indexed for MEDLINE]Related articles

    14.

    Approaching the end of the homocysteine hype?

    Sunder-Plassmann G, Winkelmayer WC, Födinger M.

    Am J Kidney Dis. 2008 Apr;51(4):549-53. No abstract available. PMID: 18371530 [PubMed]Related articles

    15.

    Pottransplantation anemia: management and rationale.

    Winkelmayer WC, Chandraker A.

    Clin J Am Soc Nephrol. 2008 Mar;3 Suppl 2:S49-55. Review.PMID: 18309003 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Phosphate binder choice in dialysis patients: a call for evidence-based rather than marketing-based clinical practice.

    Winkelmayer WC, Tonelli M.

    Am J Kidney Dis. 2008 Mar;51(3):362-5. No abstract available. PMID: 18295050 [PubMed - indexed for MEDLINE]Related articles

    17.

    Medication adherence after myocardial infarction: a long way left to go.

    Choudhry NK, Winkelmayer WC.

    J Gen Intern Med. 2008 Feb;23(2):216-8. No abstract available. PMID: 18183470 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Use of recommended medications after myocardial infarction in Austria.

    Winkelmayer WC, Bucsics AE, Schautzer A, Wieninger P, Pogantsch M; Pharmacoeconomics Advisory Council of the Austrian Sickness Funds.

    Eur J Epidemiol. 2008;23(2):153-62. Epub 2007 Dec 7.PMID: 18064529 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Long-term trends of angiotensin-converting enzyme inhibitor and angiotensin-receptor blocker use after heart failure hospitalization in community-dwelling seniors.

    Setoguchi S, Levin R, Winkelmayer WC.

    Int J Cardiol. 2008 Apr 10;125(2):172-7. Epub 2007 Nov 7.PMID: 17997175 [PubMed - indexed for MEDLINE]Related articles

    20.

    Strategies for the management of suspected heparin-induced thrombocytopenia: a cost-effectiveness analysis.

    Patrick AR, Winkelmayer WC, Avorn J, Fischer MA.

    Pharmacoeconomics. 2007;25(11):949-61.PMID: 17960953 [PubMed - indexed for MEDLINE]Related articles

    21.

    Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or =65 years of age.

    Setoguchi S, Glynn RJ, Avorn J, Levin R, Winkelmayer WC.

    Am J Cardiol. 2007 Oct 1;100(7):1061-7. Epub 2007 Jul 30.PMID: 17884362 [PubMed - indexed for MEDLINE]Related articles

    22.

    Benzodiazepine use and mortality of incident dialysis patients in the United States.

    Winkelmayer WC, Mehta J, Wang PS.

    Kidney Int. 2007 Dec;72(11):1388-93. Epub 2007 Sep 12.PMID: 17851463 [PubMed - indexed for MEDLINE]Related articles

    23.

    Cardiovascular risk and the thiazolidinediones: déjà vu all over again?

    Solomon DH, Winkelmayer WC.

    JAMA. 2007 Sep 12;298(10):1216-8. No abstract available. PMID: 17848659 [PubMed - indexed for MEDLINE]Related articles

    24.

    Kidney function and use of recommended medications after myocardial infarction in elderly patients.

    Winkelmayer WC, Charytan DM, Brookhart MA, Levin R, Solomon DH, Avorn J.

    Clin J Am Soc Nephrol. 2006 Jul;1(4):796-801. Epub 2006 May 31.PMID: 17699289 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Associations between demographic factors and provider structures on cost and length of stay for hemodialysis patients with vascular access failure.

    Brenner L, Singh AK, Campbell D, Frei F, Winkelmayer WC.

    Clin J Am Soc Nephrol. 2006 May;1(3):455-61. Epub 2006 Apr 19.PMID: 17699245 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    No associations between prolactin concentrations and response to erythropoiesis-stimulating agents in hemodialysis patients.

    Riegersperger M, van Houte M, Födinger M, Wojcik J, Hörl WH, Winkelmayer WC, Sunder-Plassmann G.

    Am J Nephrol. 2007;27(4):390-6. Epub 2007 Jun 21.PMID: 17587788 [PubMed - indexed for MEDLINE]Related articles

    27.

    Impact of Medicaid prior authorization on angiotensin-receptor blockers: can policy promote rational prescribing?

    Fischer MA, Choudhry NK, Winkelmayer WC.

    Health Aff (Millwood). 2007 May-Jun;26(3):800-7.PMID: 17485759 [PubMed - indexed for MEDLINE]Related articles

    28.

    Nononcologic use of human recombinant erythropoietin therapy in hospitalized patients.

    Fischer MA, Morris CA, Winkelmayer WC, Avorn J.

    Arch Intern Med. 2007 Apr 23;167(8):840-6.PMID: 17452549 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Early erythropoietin therapy is associated with improved growth in children with chronic kidney disease.

    Boehm M, Riesenhuber A, Winkelmayer WC, Arbeiter K, Mueller T, Aufricht C.

    Pediatr Nephrol. 2007 Aug;22(8):1189-93. Epub 2007 Mar 30.PMID: 17394020 [PubMed - indexed for MEDLINE]Related articles

    30.

    Predialysis nephrologist care and access to kidney transplantation in the United States.

    Winkelmayer WC, Mehta J, Chandraker A, Owen WF Jr, Avorn J.

    Am J Transplant. 2007 Apr;7(4):872-9.PMID: 17391130 [PubMed - indexed for MEDLINE]Related articles

    31.

    A J-shaped association between high-sensitivity C-reactive protein and mortality in kidney transplant recipients.

    Winkelmayer WC, Schaeffner ES, Chandraker A, Kramar R, Rumpold H, Sunder-Plassmann G, Födinger M.

    Transpl Int. 2007 Jun;20(6):505-11. Epub 2007 Mar 16.PMID: 17362474 [PubMed - indexed for MEDLINE]Related articles

    32.

    Statins in elderly patients with acute coronary syndrome: an analysis of dose and class effects in typical practice.

    Choudhry NK, Levin R, Winkelmayer WC.

    Heart. 2007 Aug;93(8):945-51. Epub 2007 Mar 7.PMID: 17344334 [PubMed - indexed for MEDLINE]Related articles

    33.

    Clinical presentation of myocardial infarction contributes to lower use of coronary angiography in patients with chronic kidney disease.

    Charytan DM, Setoguchi S, Solomon DH, Avorn J, Winkelmayer WC.

    Kidney Int. 2007 May;71(9):938-45. Epub 2007 Mar 7.PMID: 17342183 [PubMed - indexed for MEDLINE]Related articles

    34.

    Prognostic associations of serum calcium, phosphate and calcium phosphate concentration product with outcomes in kidney transplant recipients.

    Schaeffner ES, Födinger M, Kramar R, Sunder-Plassmann G, Winkelmayer WC.

    Transpl Int. 2007 Mar;20(3):247-55.PMID: 17291218 [PubMed - indexed for MEDLINE]Related articles

    35.

    The association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use during postischemic acute transplant failure and renal allograft survival.

    Heinze G, Collins S, Benedict MA, Nguyen LL, Kramar R, Winkelmayer WC, Haas M, Kainz A, Oberbauer R.

    Transplantation. 2006 Dec 15;82(11):1441-8.PMID: 17164715 [PubMed - indexed for MEDLINE]Related articles

    36.

    Comparison of hemodialysis and peritoneal dialysis survival in The Netherlands.

    Liem YS, Wong JB, Hunink MG, de Charro FT, Winkelmayer WC.

    Kidney Int. 2007 Jan;71(2):153-8. Epub 2006 Nov 29.PMID: 17136031 [PubMed - indexed for MEDLINE]Related articles

    37.

    Angiotensin inhibition after myocardial infarction: does drug class matter?

    Winkelmayer WC, Fischer MA, Schneeweiss S, Levin R, Avorn J.

    J Gen Intern Med. 2006 Dec;21(12):1242-7.PMID: 17105523 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    A prospective study of anaemia and long-term outcomes in kidney transplant recipients.

    Winkelmayer WC, Chandraker A, Alan Brookhart M, Kramar R, Sunder-Plassmann G.

    Nephrol Dial Transplant. 2006 Dec;21(12):3559-66. Epub 2006 Oct 13.PMID: 17040993 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Efficacy and safety of angiotensin II receptor blockade in elderly patients with diabetes.

    Winkelmayer WC, Zhang Z, Shahinfar S, Cooper ME, Avorn J, Brenner BM.

    Diabetes Care. 2006 Oct;29(10):2210-7.PMID: 17003295 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Renal dysfunction increases the risk of saphenous vein graft occlusion: results from the Post-CABG trial.

    Wellenius GA, Mukamal KJ, Winkelmayer WC, Mittleman MA.

    Atherosclerosis. 2007 Aug;193(2):414-20. Epub 2006 Aug 14.PMID: 16905139 [PubMed - indexed for MEDLINE]Related articles

    41.

    Comparison of two dosages of thymoglobulin used as a short-course for induction in kidney transplantation.

    Wong W, Agrawal N, Pascual M, Anderson DC, Hirsch HH, Fujimoto K, Cardarelli F, Winkelmayer WC, Cosimi AB, Tolkoff-Rubin N.

    Transpl Int. 2006 Aug;19(8):629-35.PMID: 16827679 [PubMed - indexed for MEDLINE]Related articles

    42.

    Surrogate markers in clinical studies: problems solved or created?

    Manns B, Owen WF Jr, Winkelmayer WC, Devereaux PJ, Tonelli M.

    Am J Kidney Dis. 2006 Jul;48(1):159-66. No abstract available. PMID: 16797400 [PubMed - indexed for MEDLINE]Related articles

    43.

    Assessing health state utilities in elderly patients at cardiovascular risk.

    Winkelmayer WC, Benner JS, Glynn RJ, Schneeweiss S, Wang PS, Brookhart MA, Levin R, Jackson JD, Avorn J.

    Med Decis Making. 2006 May-Jun;26(3):247-54.PMID: 16751323 [PubMed - indexed for MEDLINE]Related articles

    44.

    Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Codes for Acute Renal Failure.

    Waikar SS, Wald R, Chertow GM, Curhan GC, Winkelmayer WC, Liangos O, Sosa MA, Jaber BL.

    J Am Soc Nephrol. 2006 Jun;17(6):1688-94. Epub 2006 Apr 26.PMID: 16641149 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Predicting survival in patients requiring renal replacement therapy after cardiac surgery.

    Leacche M, Winkelmayer WC, Paul S, Lin J, Unic D, Rawn JD, Cohn LH, Byrne JG.

    Ann Thorac Surg. 2006 Apr;81(4):1385-92.PMID: 16564277 [PubMed - indexed for MEDLINE]Related articles

    46.

    Incidence of end-stage renal disease in patients with type 1 diabetes was 7.8% at 30 years after diagnosis.

    Winkelmayer WC.

    ACP J Club. 2006 Mar-Apr;144(2):51. No abstract available. PMID: 16539366 [PubMed]Related articles

    47.

    Endothelial progenitor cells in kidney transplant recipients.

    Steiner S, Winkelmayer WC, Kleinert J, Grisar J, Seidinger D, Kopp CW, Watschinger B, Minar E, Hörl WH, Födinger M, Sunder-Plassmann G.

    Transplantation. 2006 Feb 27;81(4):599-606.PMID: 16495809 [PubMed - indexed for MEDLINE]Related articles

    48.

    Prognostic associations between lipid markers and outcomes in kidney transplant recipients.

    Schaeffner ES, Födinger M, Kramar R, Frei U, Hörl WH, Sunder-Plassmann G, Winkelmayer WC.

    Am J Kidney Dis. 2006 Mar;47(3):509-17.PMID: 16490631 [PubMed - indexed for MEDLINE]Related articles

    49.

    Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.

    Heinze G, Mitterbauer C, Regele H, Kramar R, Winkelmayer WC, Curhan GC, Oberbauer R.

    J Am Soc Nephrol. 2006 Mar;17(3):889-99. Epub 2006 Feb 15.PMID: 16481415 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Poor short-term survival and low use of cardiovascular medications in elderly dialysis patients after acute myocardial infarction.

    Winkelmayer WC, Charytan DM, Levin R, Avorn J.

    Am J Kidney Dis. 2006 Feb;47(2):301-8.PMID: 16431259 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...